Research workbench
Crystal structure of a kunitz type trypsin inhibitor from cicer arietinuml
Analyse Crystal structure of a kunitz type trypsin inhibitor from cicer arietinuml in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 5XOZ
- Type
- protein
- Length
- 357 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Trypsin protein inhibitor 2
- UniProt
- Q9M3Z7
- Pockets
- 3 · best druggability 0.52
Structure
x-ray diffraction · 2 distinct chains · 2% helix, 42% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Trypsin protein inhibitor 2 | protein | 178 | 2% helix, 42% strand | Q9M3Z7 |
| B | Trypsin protein inhibitor 2 | protein | 179 | 2% helix, 42% strand | Q9M3Z7 |
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 122 | 0.52 | 0.81 | 26 | empty |
| 2 | 117 | 0.45 | 0.78 | 27 | empty |
| 3 | 60 | 0.30 | 0.75 | 20 | empty |
Interfaces
1 interface between chains.
- A–B · 444 Ų buried · 7 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 4 disulfide (disulfide).
Compared structures
- 5XOZ · Crystal structure of a Kunitz type trypsin inhibitor from Cicer arietinumL · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9M3Z7
- Elsewhere: RCSB PDB 5XOZ · PDBe 5XOZ · UniProt Q9M3Z7
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.